Day 1 - Breast Cancer Update - 9 Oct 2020
VIRTUAL UPDATE 4th Annual International PRECISION ONCOLOGY & IBC CONFERENCE JAIPUR

Part 1 - Welcome and Introduction - Dr. Sandeep Jasuja, Jaipur & Dr. B K Smruti, Mumbai
Part 2 - Genomic tools and clinical decisions: Ideal vs real world - Dr. Amit Agarwal, Delhi
Part 3 - Prognostication of HR+/HER2 - EBC patients in India: Can Assist Breast - Dr. Manjiri Bakre
Part 4 - Panel Discussion: Virtual Tumor - Dr. K Govind Babu, Bengaluru
Part 5 - Recent advances in adjuvant HER 2 neu positive breast cancer - Dr. Ajay Bapna, Jaipur
Part 6 - Neo-adjuvant therapy, residual disease, and optimizing adjuvant therapy - Dr. B.K.Smruti
Part 7 - HER2+VE MBC and brain Mets what's new? - Dr. M. Vamshi Krishna, Hyderabad
Part 8 - Treatment of triple-positive disease an enigma with cross-talks - Dr. Amit Rauthan
Part 10 -Panel Discussion: Virtual Tumor Board: Operable Breast Cancer - MRM/Neoadjuvant? -Dr. Seema
Part 11 - Words of wisdom and take home message - Dr. Mukul Goyal, Jaipur

Day 2 - Lung Cancer Update - 10 Oct 2020
VIRTUAL UPDATE 4th Annual International PRECISION ONCOLOGY & IBC CONFERENCE JAIPUR

Part 1 - Welcome and Introduction - Dr. Sandeep Jasuja, Jaipur
Part 2 - Immunotherapy current scenario and future trends in Lung Cancer - Dr. Balazs Halmos
Part 3 - IM power 133-Tecentriq plus chemo in 1L ES-SCLC - Dr. Kumar Prabhash, Mumbai
Part 4 - Optimal management of EGFR m NSCLC patients - Dr. Shyam Agarwal, Delhi
Part 5 - Screening diagnosis & Molecular Marker in Lung Cancer - Dr. Lim, Kiat Hon Tony, Singapore
Part 6 - Immune related adverse events with PDL1 and ctla4 inhibitors - Dr. Raya Leibowitz, Israel
Part 7 - Panel Discussion: Management of early stage Lung Cancer - Virtual Tumor Board - Dr. Raman
Part 8 - Case based Panel Discussion - Dr. Palanki Satya Dattatreya, Hyderabad
Part 9-Virtual Tumor Board: Immune Checkpoint Inhibitors in the management of Lung Cancer- Dr. Ullas
Part 10 - Advances in the Management of Triple –Negative Breast Cancer - Dr. Lee Soo Chin, Singapore
Part 11 - Panel Discussion: Virtual Tumor Board : TNBC - New Horizons? - Dr. Shyam Aggarwal, Delhi
Part 12 - Take home message & Vote of Thanks - Dr. Ankush Rathi, Jaipur

Day 3 - Gastrointestinal Cancer Update - 11 Oct 2020
VIRTUAL UPDATE 4th Annual International PRECISION ONCOLOGY & IBC CONFERENCE JAIPUR

Part 1 - Welcome and Introduction - Dr. Sandeep Jasuja, Jaipur
Part 2 - Nivolumab with chemotherapy in advanced previously untreated Gastric - Dr. Anant Ramaswamy
Part 3 - Novel targets and agents in gastroesophageal cancers - Dr. Mohit Agarwal, Delhi
Part 4 - Tumor Board Discussion - Dr. T P Sahoo, Bhopal
Part 5 - Immunotherapy in HCC - Dr. Sumit Goyal, Delhi
Part 6 - Debate: First line therapy in Left sided , RAS / BRAF WT cancer EGFR vs VEGF
Part 7 - Tumor Board Discussion - Dr. Manikandan D, Chennai
Part 8 - Novel Targeted agents on MCRC - Dr. Bharat Vaswani, Hyderabad
Part 9 - Take home Message - Dr. Preeti Agarwal, Jaipur

Day 3 - Hematological Maligancies Update - 11 Oct 2020
VIRTUAL UPDATE 4th Annual International PRECISION ONCOLOGY & IBC CONFERENCE JAIPUR

Part 1 - Current Management of Invasive Fungal Infections in Haemato-Oncology - Dr. Aditi Mittal
Part 2 - Role of Romiplostim in CIT Management - Dr. Lalit Mohan Sharma, Jaipur
Part 3 - Tumor Board Discussion - Dr. Hari Menon, Bengaluru
Part 6 - Role of 2nd generation BTKi in the management of CLL - Dr. Suresh Babu MC, Bengaluru
Part 7 - New Era of CAR-T in Lymphoma - Dr. Swaminathan P. Iyer, USA
Part 8 - Take home message and Vote of Thanks - Dr. Hemant Malhotra, Jaipur